Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors

Clinical trial NCT01736917 · COMPLETED

Trial details

NCT number: NCT01736917
Sponsor: Lawrence Einhorn
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chemotherapy-Induced Nausea and Vomiting

Start date: 2013-01-01
Primary completion: 2015-03-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.